Elsevier,
Overcoming Obstacles in Drug Discovery and Development
Surmounting the Insurmountable—Case Studies for Critical Thinking
2023, Pages 215-222
This content aligns with Goal 3: Good Health and Wellbeing by identifying the reactive metabolite responsible for the species-specific nephrotoxicity observed in rats dosed with efavirenz provide a framework for addressing nonclinical toxicities and clinical risk and providing a solid scientific basis for regulatory review.
Ticks: Biology, Ecology, and Diseases, 2023, Pages 193-215
This chapter advances the UN SDG Goal 3: Good Health by covering the range of approaches to the control of tick and tick-borne diseases.
Elsevier,
Clinical Immunology (Sixth Edition): Principles and Practice, 2023, Pages 972-982
This content supports the SDG Goal 3: Good health and well-being by exploring the main characteristics of AIH, PBC, and PSC, with particular interest for the clinical manifestations, pathogenesis, autoantibodies, and therapeutic options.
Elsevier,
Clinical Immunology (Sixth Edition): Principles and Practice, 2023, Pages 972-982
This content supports the SDG Goal 3: Good health and well-being by exploring the main characteristics of AIH, PBC, and PSC, with particular interest for the clinical manifestations, pathogenesis, autoantibodies, and therapeutic options.
Elsevier,
Resilient and Sustainable Cities: Research, Policy and Practice, 2022, Pages 519-535
This chapter advances the UN SDG goals 11, 12, and 13 by offering two alternate approaches to Western planning—city making informed by biophilic systems and First Nations values—through Australian case studies that have similar systems of thought, aspirations, and values. The challenge is for use to adapt (or retrofit) our cities to redress climate change and our consumption values toward crafting robust, resilient, respectful and sustainable places.
